Understanding how ZIC genes affect oncogenic pathways not only provides insights into tumor biology but also opens avenues for developing targeted therapies that could manipulate these genes for clinical benefit by either inhibiting their oncogenic functions or enhancing their tumor suppressor activities [70, 71]. The gene discussed is ZIC1; the disease is neoplasm.